JAN 12, 2019 12:02 AM PST

The Harms of Prescription Sleeping Pills

WRITTEN BY: Nouran Amin

In a study published by Frontiers in Behavioral Neuroscience, one of the main class of prescription sleeping pills was found to reduce the ability to wake up to dangerous alerting signals. In particular, the study found that half the participants could not wake-up from the sound of a fire alarm as loud as the sound of a vacuum next to their bed.

Even while sleeping the brain continuously processes sensory information and will wake us up if a threat was detected—such as a loud bang. The most widely prescribed sleeping pills are benzodiazepines, which will most likely not rouse in response to sensory input. "Benzodiazepines stimulate the widespread brain receptor GABA-A, which makes us sleepy but also suppresses off-target brain areas -- including the 'gatekeeper' that decides which sensory inputs to process," says study senior author, Professor Tomoyuki Kuwaki of Kagoshima University, Japan.

However, the last decade included the development of a new class of hypnotic drugs known as dual orexin receptor antagonists (DORAs). These drugs work by selectively targeting certain sleep/wake pathways in the brain—making them more advantageous in regards to safety over benzodiazepines, including a reduced 'hangover effect' that will less likely affect driving ability after use.

Learn more about the science of sleeping:

The researchers then hypothesized that the selectivity of DORAs could be a safer alternative, than another tested benzodiazepine called triazolam since it was confirmed in model mice that DORA-22 allowed the mice to sleep but still wake to a threat. "DORA-22 and triazolam had similar sleep promoting effects, extending the duration of deep sleep by 30-40% compared to placebo," reported Kuwaki. "As expected, arousal in response to these threatening stimuli was delayed significantly in the triazolam treatment, but not in the DORA-22 treatment, compared to placebo.

However, to help confirm the safety and efficacy of the sleep-promoting effect of DORA in humans—clinical studies are needed after approval. "Although it remains to be seen whether DORAs have the same properties when used in humans, our study provides important and promising insight into the safety of these hypnotics."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 19, 2019
Technology
DEC 19, 2019
Can a 'Lemon' help develop new drugs?
Although artificial intelligence has many advantages in the drug discovery process, challenges still remain--one being the ability for machine learning to ...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Should You Really be Scared of the Coronavirus?
As of February 21st, the death toll for coronavirus reached 2,250, 55,707 currently infected, of which 12,066 (22%) are in a serious or critical condition....
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexletol, works differently from existi...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
Treating stroke with low dose of clot-busting drug
A study concludes that a low-dose of the clot-busting drug—tenecteplase—may be beneficial for eligible stroke patients that do not need an inte...
Loading Comments...